Stay updated on Pembrolizumab in Recurrent Respiratory Papilloma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Recurrent Respiratory Papilloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Recurrent Respiratory Papilloma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    - Added a site-wide notice about a lapse in government funding and NIH Clinical Center status with references to cc.nih.gov and opm.gov. Updated the page revision to v3.4.1, replacing the previous v3.4.0.
    Difference
    0.5%
    Check dated 2026-02-03T23:44:05.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Footer and header metadata were updated to include new labels such as 'Last Update Submitted that Met QC Criteria' and 'Last Update Posted', the glossary toggle option, and a revision note 'Revision: v3.4.0'. No changes were made to the study content or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-01-27T21:14:56.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    48 days ago
    Change Detected
    Summary
    A unified Locations section appears with Illinois and Massachusetts, replacing prior separate location headings. The revision is updated to v3.3.3.
    Difference
    0.4%
    Check dated 2025-12-23T09:10:25.000Z thumbnail image
  5. Check
    76 days ago
    Change Detected
    Summary
    Revision note updated from v3.2.0 to v3.3.2. There are no user-facing changes to the study details.
    Difference
    0.1%
    Check dated 2025-11-24T17:05:38.000Z thumbnail image
  6. Check
    83 days ago
    Change Detected
    Summary
    The government funding lapse notice and operating-status information (including links to cc.nih.gov and opm.gov) has been removed from the page. This notice previously informed users about potential delays and where to check status updates.
    Difference
    0.4%
    Check dated 2025-11-17T15:04:34.000Z thumbnail image
  7. Check
    98 days ago
    Change Detected
    Summary
    No significant additions or deletions were detected; core study information (title, purpose, eligibility, endpoints) and the page’s primary functions remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-03T01:32:25.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Recurrent Respiratory Papilloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Recurrent Respiratory Papilloma Clinical Trial page.